Caissa Capital Management ltd. - May 31, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Stock symbol
AVTX
Transactions as of
May 31, 2023
Transactions value $
$2,422
Form type
4
Date filed
6/2/2023, 04:22 PM
Previous filing
May 30, 2023
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $2.42K +844 +0.06% $2.87* 1.39M May 31, 2023 See Footnote (1) F1
holding AVTX Common Stock 182K May 31, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 These shares are directly owned by Mr. Golestaneh in his personal capacity.